BioSig Technologies, Inc. Common Stock
BioSig Technologies, Inc., a medical technology company, provides digital signal processing technology platform services in the United States. The company offers PURE EP Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. It has a research agreement with Mayo Foundation with the right to sublicense for patent applications in the fields of… Read more
BioSig Technologies, Inc. Common Stock (BSGM) - Total Assets
Latest total assets as of June 2025: $109.72 Million USD
Based on the latest financial reports, BioSig Technologies, Inc. Common Stock (BSGM) holds total assets worth $109.72 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BioSig Technologies, Inc. Common Stock - Total Assets Trend (2013–2024)
This chart illustrates how BioSig Technologies, Inc. Common Stock’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BioSig Technologies, Inc. Common Stock - Asset Composition Analysis
Current Asset Composition (December 2024)
BioSig Technologies, Inc. Common Stock's total assets of $109.72 Million consist of 40.9% current assets and 59.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 16.9% |
| Accounts Receivable | $109.00K | 13.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $270.00K | 32.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how BioSig Technologies, Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BioSig Technologies, Inc. Common Stock's current assets represent 40.9% of total assets in 2024, a decrease from 85.8% in 2013.
- Cash Position: Cash and equivalents constituted 16.9% of total assets in 2024, down from 85.8% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 32.0% of total assets, an increase from 0.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 32.1% of total assets.
BioSig Technologies, Inc. Common Stock Competitors by Total Assets
Key competitors of BioSig Technologies, Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
BioSig Technologies, Inc. Common Stock - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - BioSig Technologies, Inc. Common Stock generates 0.05x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - BioSig Technologies, Inc. Common Stock is currently not profitable relative to its asset base.
BioSig Technologies, Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.03 | 0.80 | 6.83 |
| Quick Ratio | 0.03 | 0.80 | 6.67 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-110.20 Million | $ -590.00K | $ 28.93 Million |
BioSig Technologies, Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between BioSig Technologies, Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 36.58 |
| Latest Market Cap to Assets Ratio | 15.61 |
| Asset Growth Rate (YoY) | -53.2% |
| Total Assets | $842.00K |
| Market Capitalization | $13.15 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values BioSig Technologies, Inc. Common Stock's assets at a significant premium ( 15.61x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: BioSig Technologies, Inc. Common Stock's assets decreased by 53.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for BioSig Technologies, Inc. Common Stock (2013–2024)
The table below shows the annual total assets of BioSig Technologies, Inc. Common Stock from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $842.00K | -53.17% |
| 2023-12-31 | $1.80 Million | -56.25% |
| 2022-12-31 | $4.11 Million | -73.52% |
| 2021-12-31 | $15.52 Million | -48.93% |
| 2020-12-31 | $30.39 Million | +113.73% |
| 2019-12-31 | $14.22 Million | +184.52% |
| 2018-12-31 | $5.00 Million | +193.88% |
| 2017-12-31 | $1.70 Million | +36.91% |
| 2016-12-31 | $1.24 Million | +20.51% |
| 2015-12-31 | $1.03 Million | +191.66% |
| 2014-12-31 | $353.34K | +0.37% |
| 2013-12-31 | $352.05K | -- |